ONYX BIOTEC Share price
ONYX
49.5
0.25 (0.51%)Last updated on 23 May, 2025 | 14:55 IST
Today's High
49.50
Today's Low
49.50
52 Week Low
48.05
52 Week High
97.45
The current prices are delayed, login to your account for live prices
LoginOnyx Biotec Chart
ONYX BIOTEC Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
30.11
Sector P/B
3.8
Sec. Div. Yield
0.52
ONYX BIOTEC Resistance and Support
Pivot 49.38
Resistance
First Resistance
49.51
Second Resistance
49.78
Third Resistance
49.91
Support
First Support
49.11
Second Support
48.98
Third Support
48.71
ONYX BIOTEC Corporate Actions
| Date | Agenda | ||
|---|---|---|---|
 | |||
| Date | Event Type | Agenda | |
|---|---|---|---|
| |||
ONYX BIOTEC News
Onyx Biotec shares debut at 11% discount on NSE SME platform today
Nov 22 2024 11:31:54
Onyx Biotec shares list at 11% discount below IPO price on NSE SME
Nov 22 2024 10:21:50
Onyx Biotec shares list at 11% discount below IPO price on NSE SME
Nov 22 2024 10:16:50
About ONYX BIOTEC AboutThe
NSE : 27136
BSE : 212187
ISIN : INE0WVU01018
Our Company was incorporated on May 13 2005 as a private limited company as ‘Onyx Biotec Private Limited’ under the Companies Act 1956 pursuant to a certificate of incorporation dated May 13 2005 issued by the Registrar of Companies Punjab H.P. & Chandigarh. Further our Company was converted into a public limited company pursuant to a resolution passed by our Board of Directors in its meeting held on May 1 2024 and by the Shareholders in an Extraordinary General Meeting held on May 27 2024 and consequently the name of our Company was changed to ‘Onyx Biotec Limited’ and a fresh certificate of incorporation dated July 23 2024 was issued by the Registrar of Companies Central Processing Centre. The corporate identification number of our Company is U24230HP2005PLC028403.Major Events and Milestones:2010-Our Company commenced commercial production at our Unit I with two line of Form Fill and Seal setup with capacity of 2 lacs units per day2017-Capacity expansion at our Unit I from 130 million unit per annum to 230 million units per annum-Our Company received a certificate for Good Manufacturing Practice from Deputy Drugs Controller cum Licensing Authority Health & Family2023-Our Company commenced commercial production at our Unit II
ONYX BIOTEC Management
| Name | Position |
|---|---|
| Mr. Sanjay Jain | Managing Director |
| Mr. Harsh Mahajan | Whole-time Director & CFO & CEO |
| Mr. Naresh Kumar | Whole Time Director |
| Ms. Lakshya Jain | Whole Time Director |
| Mr. Parmjeet Kaur | Non Executive Director |
ONYX BIOTEC Similar Stocks